Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions

European Journal of Cell Biology

Volumn 74, Issue 2, 1997, Pages 111-122

  Gomez, Daniel E ^a   Alonso, Daniel F ^a   Yoshiji, Hitoshi ^b   Thorgeirsson, Unnur P ^b,c  

^a UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cell biology; Extracellular matrix; Physiopathology; Tissue inhibitor of metalloproteinases; Tissue remodeling

Indexed keywords

CELL MARKER; GROWTH FACTOR; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

AMINO ACID SEQUENCE; ANGIOGENESIS; CANCER INVASION; CELL CYCLE; CELL DIFFERENTIATION; CELL STRUCTURE; DEGENERATIVE DISEASE; EMBRYO DEVELOPMENT; ENZYME REGULATION; ENZYME STRUCTURE; EXTRACELLULAR MATRIX; GENITAL SYSTEM; GONAD; GROWTH STIMULATION; HEMOSTASIS; HUMAN; INFLAMMATION; METASTASIS; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SCIENTIFIC LITERATURE; STEROIDOGENESIS; STRUCTURE ACTIVITY RELATION; TISSUE SPECIFICITY; TUMOR GROWTH;

AMINO ACID SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0030717692     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (176)

1. Agrez, M. V., C. J. Meldrum, A. T. R. Sim, R. H. Aebersold, I. M. Clark, T. E. Cawston, G. F. Burns: A fibroblast elongation factor purified from colon carcinoma cells shares sequence identity with TIMP-1. Biochem. Biophys. Res. Commun. 206, 590-600 (1995).
2. Albini, A., A. Melchiori, L. Santi, L. A. Liotta, P. D. Brown, W. G. Stetler-Stevenson: Tumor cell invasion inhibited by TIMP-2. J. Natl. Cancer Inst. 83, 775-779 (1991).
3. Alexander, C. M., E. J. Hansell, O. Behrendtsen, M. L. Flannery, N. S. Kishnani, S. P. Hawkes, Z. Werb: Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 122, 1723-1736 (1996).
4. Alexander, C. M., Z. Werb: Extracellular matrix degradation. In: E. D Hay (eds.): Cell Biology of the Extracellular Matrix. pp. 255-302. Plenum Press. New York 1991.
5. Alexander, C. M., Z. Werb: Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro. J. Cell Biol. 118, 727-739 (1992).
6. Alvarez, O. A., D. F. Carmichael, Y. A. DeClerck: Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J. Natl. Cancer Inst. 82, 589-595 (1990).
7. Apte, S. S., B. R. Olsen, G. Murphy: The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J. Biol. Chem. 270, 14313-14318 (1995).
8. Avalos, B. R., S. E. Kaufman, M. Tomonaga, R. E. Williams, D. W. Golde, J. C. Gasson: K562 cells produce and respond to human erythroid potentiating activity. Blood 71, 1720-1725 (1988).
9. Ballin, M., D. E. Gomez, C. C. Sinha, U. P. Thorgeirsson: Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. Biochem. Biophys. Res. Commun. 154, 832-838 (1988).
10. Ballin, M., A. R. Mackay, J. L. Hartzler, A. Nason, M. D. Pelina, U. P. Thorgeirsson: Ras levels and metalloproteinase activity in normal versus neoplastic rat mammary tissues. Clin. Exp. Metastasis 9, 179-189 (1991).
11. Barsky, S. H., R. Gopalakrishna: High metalloproteinase inhibitor content of human cirrhosis and its possible conference of metastasis resistance. J. Natl. Cancer Inst. 80, 102-108 (1988).
12. Behrendtsen, O., C. M. Alexander, Z. Werb: Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowth. Development 114, 447-456 (1992).
13. Bertaux, B., W. Hornebeck, A. Z. Eisen, L. Dubertret: Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J. Invest. Dermatol. 97, 679-685 (1991).
14. Birkedal-Hanse, H.: Role of matrix metalloproteinases in human periodontal diseases. J. Periodontol. 64, 474-484 (1993).
15. Birkedal-Hansen, H.: Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7, 728-735 (1995).
16. Birkedal-Hansen, H., W. G. I. Moore, M. K. Bodden, L. J. Windsor, B. Birkedal-Hansen, A. DeCarlo, J. A. Engler: Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4, 197-250 (1993).
17. Bodden, M. K., G. J. Harber, B. Birkedal-Hansen, L. J. Windsor, N. C. M. Caterina, J. A. Engler, H. Birkedal-Hansen: Functional domains of human TIMP-1 (tissue inhibitor of metalloproteinases). J. Biol. Chem. 269, 18943-18952 (1994).
18. Bodden, M. K., L. J. Windsor, N. C. M. Caterina, A. Yermovsky, B. Birkedal-Hansen, G. Galazka, J. A. Engler, H. Birkedal-Hansen: Analysis of the TIMP-1/FIB-CL complex. Ann. N.Y. Acad. Sci. 732, 84-95 (1994).
19. Boone, T. C., M. J. Johnson, Y. A. DeClerck, K. E. Langley: cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc. Natl. Acad. Sci. USA 87, 2800-2804 (1990).
20. Boudreau, N., C. Myers, M. J. Bissell: From laminin to laminin: regulation of tissue-specific gene expression by the ECM. Trends Cell Biol. 5, 1-5 (1995).
21. Boudreau, N., C. J. Sympson, Z. Werb, M. J. Bissell: Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267, 891-893 (1995).
22. Boujrad, N., S. O. Ogwuegbu, M. Garnier, C. H. Lee, B. M. Martin, V. Papadopoulos: Identification of a stimulator of steroid hormone synthesis isolated from testis. Science 268, 1609-1612 (1995).
23. Brenner, C. A., R. R. Adler, D. A. Rappolee, R. A. Pedersen, Z. Werb: Genes for extracellular matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development. Genes Dev. 3, 848-859 (1989).
24. Brian, J., Y. Wang, M. R. Smith, H. Kim, C. Jacobs, J. Jackman, H. F. Kung, N. H. Colburn, Y. Sun: Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP-3). Carcinogenesis 9, 1805-1811 (1996).
25. Brinckerhoff, C. E.: Regulation of metalloproteinase gene expression: implications for osteoarthritis. Crit. Rev. Eukaryotic Gene Expression 2, 145-164 (1992).
26. Brown, P. D., R. Giavazzi: Matrix metalloproteinase inhibition: a review of anti-tumour activity. Ann. Oncol. 6, 967-974 (1995).
27. Bugno, M., L. Graeve, P. Gatsios, A. Koj, P. C. Heinrich, J. Travis, T. Kordula: Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. Nucleic Acids Res. 23, 5041-5047 (1995).
28. Byrne, J. A., C. Tomasetto, N. Rouyer, J. P. Bellocq, M. C. Rio, P. Basset: The tissue inhibitor of metalloproteinases-3 gene in breast carcinoma: identification of multiple polyadenylation sites and a stromal pattern of expression. Mol. Med. 1, 418-427 (1995).
29. Campbell, C. E., A. M. Flenniken, D. Skup, B. R. C. Williams: Identification of a serum- and phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene. J. Biol. Chem. 266, 7199-7206 (1991).
30. Carmichael, D. F., A. Sommer, R. C. Thompson, D. C. Anderson, C. G. Smith, H. G. Welgus, G. P. Stricklin: Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc. Natl. Acad. Sci. USA 83, 2407-2411 (1986).
31. Carmichael, D. F., G. P. Stricklin, J. M. Stuart: Systemic administration of TIMP in the treatment of collagen-induced arthritis in mice. Agents Actions 27, 378-379 (1989).
32. Cawston, T., T. Plumpton, V. Curry, A. Ellis, L. Powell: Role of TIMP and MMP inhibition in preventing connective tissue breakdown. Ann. N.Y. Acad. Sci. 732, 75-83 (1994).
33. Cawston, T. E.: Protein inhibitors of metalloproteinases. In: A. J. Barret, G. Salvesen (eds.): Proteinase Inhibitors. pp. 589-610. Elsevier. Amsterdam 1986.
34. Chester, L., D. W. Golde, N. Bersch, M. D. Johnson: Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Blood 86, 4506-4515 (1995).
35. Clark, S. D., D. K. Kobayashi, H. G. Welgus: Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J. Clin. Invest 80, 1280-1288 (1987).
36. Cook, T. F., J. S. Burke, K. D. Bergman, C. O. Quinn, J. J Jeffrey, N. C. Partridge: Cloning and regulation of rat tissue inhibitor of metalloproteinases-2 in osteoblastic cells. Arch. Biochem. Biophys. 311, 313-320 (1994).
37. Corcoran, M. L., M. R. Emmert-Buck, J. L. McClanahan, M. Pelina-Parker, W. G. Stetler-Stevenson: TIMP-2 mediates cell surface binding of MMP-2. Adv. Exp. Med. Biol. 389, 295-304 (1996).
38. Crawford, H. C., L. M. Matrisian: Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 14, 234-245 (1994).
39. Dean, D. D., J. Martel-Pelletier, J. P. Pelletier, D. S. Howell, J. F. Woessner: Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J. Clin. Invest. 84, 678-685 (1989).
40. DeClerck, Y., C. Szpirer, M. S. Aly, J. J. Cassiman, Y. Eeckhout, G. Rousseau: The gene for tissue inhibitor of metalloproteinases-2 is localized on human chromosome arm 17q25. Genomics 14, 782-784 (1992).
41. DeClerck, Y. A., M. I. Darville, Y. Eeckhout, G. G. Rousseau: Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene 139, 185-191 (1994).
42. DeClerck, Y. A., N. Perez, H. Shimada, T. C. Boone, K. E. Langley, S. M. Taylor: Inhibition of invasion and metastasis in cell transfected with an inhibitor of metalloproteinases. Cancer Res. 52, 701-708 (1992).
43. DeClerck, Y. A., T. D. Yean, D. Chan, H. Shimada, K. E. Langley: Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res. 51, 2151-2157 (1991).
44. DeClerck, Y. A., T. D. Yean, Y. Lee, J. M. Tomich, K. E. Langley: Characterization of the functional domain of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochem. J. 289, 65-69 (1993).
45. DeClerck, Y. A., T. D. Yean, B. J. Ratzkin, H. S. Lu, K. E. Langley: Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J. Biol. Chem. 264, 17435-17453 (1989).
46. Denhardt, D. T., B. Feng, D. R. Edwards, E. T. Cocuzzi, U. M. Malyankar: Tissue inhibitor of metalloproteinases (TIMP, aka EPA): Structure, control of expression and biological functions. Pharmacol. Ther. 59, 329-341 (1993).
47. Docherty, A. J. P., A. Lyons, B. J. Smith, E. M. Wright, P. E. Stephens, T. J. R. Harris, G. Murphy, J. J. Reynolds: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid potentiating activitiy. Nature 318, 65-69 (1985).
48. Edwards, D. R., H. Rocheleau, R. R. Sharma, A. J. Wills, A. Cowie, J. A. Hassell, J. K. Heath: Involvement of AP-1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim. Biophys. Acta 1171, 41-55 (1992).
49. Edwards, D. R., P. Waterhouse, M. L. Holman, D. T. Denhardt: A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythoid-potentiating activity: evidence for inducible and constitutive transcripts. Nucleic Acids Res. 14, 8863-8878 (1986).
50. Emmert-Buck, M. R., H. P. Emonard, M. L. Corcoran, H. C. Krutzsch, J. Foidart, W. G. Stetler-Stevenson: Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex. FEBS Lett. 364, 28-32 (1995).
51. Flenniken, A .M., B. R. G. Williams: Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice. Genes Dev. 4, 1094-1106 (1990).
52. Freudenstein, J., S. Wagner, R. M. Luck, R. Einspanier, K. H. Scheit: mRNA of bovine tissue inhibitor of metalloproteinase: sequence and expression in bovine ovarian tissue. Biochem. Biophys. Res. Commun. 171, 250-256 (1990).
53. Fridman, R., T. R. Fuerst, R. E. Bird, M. Hoyhtya, M. Delkuct, S. Kraus, D. Komarek, L. A. Liotta, M. L. Berman, W. G. Stetler-Stevenson: Domain structure of human 72-kDa gelatinase/type IV collagenase. J. Biol. Chem. 267, 15398-15405 (1992).
54. Fukuda, Y., M. Imoto, Y. Koyama, Y. Miyazawa, I. Nakano, M. Hattori, F. Urano, S. Kodama, K. Iwata, T. Hayakawa: Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers. Gastroenterol. Jpn. 26, 37-41 (1991).
55. Ganser, G. L., G. P. Stricklin, L. M. Matrisian: EGF and TGF alpha influence in vitro lung development by the induction of matrix-degrading metalloproteinases. Int. J. Dev. Biol. 35, 453-461 (1991).
56. Gasson, J. C., D. W. Golde, S. B. Kaufman, C. A. Westbrook, R. M. Hewick, R. J. Kaufman, G. G. Wong, P. A. Temple, A. C. Leary, E. L. Brown, E. C. Orr, S. C. Clarck: Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 315, 768-771 (1985).
57. Gewert, D. R., B. Coulombe, M. Castelino, D. Skup, B. R. G. Williams: Characterization and expression of a murine gene homologous to human EPA/TIMP: a virus-induced gene in the mouse. EMBO J. 6, 651-657 (1987).
58. Goldberg, G. I., B. L. Marmer, G. A. Grant, A. Z. Eisen, S. Wilhelm, C. He: Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2. Proc. Natl. Acad. Sci. USA 86, 8207-8211 (1989).
59. Goldberg, G. I., A. Strongin, I. E. Collier, L. T. Genrich, B. L. Marmer: Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267, 4583-4591 (1992).
60. Golde, D. W., N. Bersch, S. G. Quau, A. J. Lusis: Production of erythroid-potentiating activity by a human T-lymphoblast cell line. Proc. Natl. Acad. Sci. USA 77, 593-596 (1980).
61. Gomez, D. E., C. K. Lindsay, D. W. Cottam, A. M. Nason, U. P. Thorgeirsson: Expression and characterization of human tissue inhibitor of metalloproteinases-1 in a baculovirus-insect cell system. Biochem. Res. Commun. 203, 237-243 (1994).
62. Gray, R. D., C. A. Paterson: Application of peptide-based matrix metalloproteinase inhibitors in corneal ulceration. Ann. N. Y. Acad. Sci. 732, 206-216 (1994).
63. Greene, J., M. Wang, Y. E. Liu, L. A. Raymond, C. Rosen, Y. E. Shi: Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271, 30375-30380 (1996).
64. Grignon, D. J., W. Sakr, M. Toth, V. Ravery, J. Angulo, F. Shamsa, J. E. Pontes, J. C. Crissman, R. Fridman: High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res. 56, 1654-1659 (1996).
65. Halaka, A. N., R. A. D. Bunning, C. C. Bird, M. Gibson, J. J. Reynolds: Production of collagenase and inhibitor (TIMP) by intracranial tumors and dura in vitro. J. Neurosurg. 59, 461-466 (1983).
66. Hayakawa, T., K. Yamashita, E. Ohuchi, A. Shinagawa: Cell growth-promoting activity of tissue inhibitor of metalloproteinase-2 (TIMP-2). J. Cell Sci. 107, 2373-2379 (1994).
67. Hayakawa, T., K. Yamashita, K. Tanzawa, E. Uchijima, K. Iwata: Growth promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. FEBS Lett. 298, 29-32 (1992).
68. Heine, U. I., E. F. Munoz, K. C. Flanders, L. R. Ellingsworth, H. Y. P. Lam, N. L. Thompson, A. B. Roberts, M. B. Sporn: Role of transforming growth factor-β in the development of the mouse embryo. J. Cell Biol. 105, 2861-2876 (1987).
69. Herron, G. S., E. Unemori, M. Wong, J. H. Rapp, M. H. Hibbs, R. J. Stoney: Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Arterioscler. Thromb. 11, 1667-1677 (1991).
70. Hicks, N. J., R. V. Ward, J. J. Reynolds: A fibrosarcoma model derived from mouse embryo cells: growth properties and secretion of collagenase and metalloproteinase inhibitor (TIMP) by tumour cell lines. Int. J. Cancer 33, 835-844 (1984).
71. Hill, P. A., J. J. Reynolds, M. C. Meikle: Inhibition of stimulated bone resorption in vitro by TIMP-1 and TIMP-2. Biochim. Biophys. Acta 1177, 71-74 (1993).
72. Horowitz, S., N. Dafni, D. L. Shapiro, B. A. Holm, R. H. Notter, D. J. Quible: Hyperoxic exposure alters gene expression in the lung. J. Biol. Chem. 264, 7092-7095 (1989).
73. Howard, E. W., M. J. Banda: Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. J. Biol. Chem. 266, 17972-17977 (1991).
74. Huang, W., K. Suzuki, H. Nagase, S. Arumugam, S. R. Van Doren, K. Brew: Folding and characterization of the amino-terminal domain of human tissue inhibitor of metalloproteinases-1 (TIMP-1) expressed at high yield in E. coli. FEBS Lett. 384, 155-161 (1996).
75. Huebner, K., M. Isobe, J. C. Gasson, D. W. Golde, C. M. Croce: Localization of the gene encoding erythroid potentiating activity to chromosome region Xp11.1-Xp11.4. Am. J. Hum. Genet. 38, 819-826 (1986).
76. Hurskainen, T., Y. Soini, A. Tuuttila, M. Hoyhtya, A. Oikarinen, H. Autio-Harmainen: Expression of the tissue metalloproteinase inhibitors TIMP-1 and TIMP-2 in malignant fibrous histiocytomas and dermatofibromas as studied by in situ hybridization and immunohistochemistry. Hum. Pathol. 27, 42-49 (1996).
77. Imren, S., D. B. Kohn, H. Shimada, L. Blavier, Y. A. DeClerck: Overexpression of tissue inhibitor of metalloproteinases-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res. 56, 2891-2895 (1996).
78. Ito, A., T. Sato, T. Iga, Y. Mori: Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. FEBS Lett. 269, 93-95 (1990).
79. Jeffrey, J. J.: Collagen and collagenase: pregnancy and parturition. Semin. Perinatol. 15, 118-126 (1991).
80. Jeffrey, J. J.: Collagen degradation. In: R. F. Diegelmann, W. J. Lindblad (eds.): Wound Healing: Biochemical and Clinical Aspects. pp. 177-194. Saunders Company. Philadelphia 1992.
81. Johnson, M. D., G. M. Housey, P. T. Kirschmeier, I. B. Weinstein: Molecular cloning of gene sequences regulated by tumor promoters and mitogens through protein kinase C. Mol. Cell. Biol. 7, 2821-2829 (1987).
82. Johnson, M. D., H. R. C. Kim, L. Chesler, G. Tsao-Wu, N. Bouck, P. J. Polverini: Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J. Cell. Physiol. 160, 194-202 (1994).
83. Khokha, R., P. Waterhouse, S. Yagel, P. K. Lala, C. M. Overall, G. Norton, D. T. Denhardt: Antisense RNA-induced reduction in murine TIMP levels confers oncogcnicity on Swiss 3T3 cells. Science 243, 947-950 (1989).
84. Khokha, R., M. J. Zimmer, C. H. Graham, P. K. Lala, P. Waterhouse: Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J. Natl. Cancer Inst. 84, 1017-1022 (1992).
85. Kinoshita, T., H. Sato, T. Takino, M. Itoh, T. Akizawa, M. Seiki: Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Cancer Res. 56, 2535-2538 (1996).
86. Kleine, T., S. Bartsch, J. Blaser, S. Schnierer, S. Triebel, M. Valentin, T. Gote, H. Tschesche: Preparation of active recombinant TIMP-1 from Escherichia coli inclusion bodies and complex formation with the recombinant catalytic domain of PMNL-collagenase. Biochemistry 32, 14125-14131 (1993).
87. Kleiner, D. E., E. J. Unsworth, H. C. Krutzsch, W. G. Stetler-Stevenson: Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2. Biochemistry 31, 1665-1672 (1993).
88. Kolkenbrock, H., D. Orgel, A. Hecker-Kia, W. Noack, N. Ulbrich: The complex between a tissue inhibitor of metalloproteinase (TIMP-2) and 72 kDa progelatinase is a metalloproteinase inhibitor. Eur. J. Biochem. 198, 775-781 (1991).
89. Kolkenbrock, H., D. Orgel, A. Hecker-Kia, J. Zimmermann, N. Ulbrich: Generation and activity of ternary gelatinase B/TIMP-1/ LMW-stromelysin-1 complex. Biol. Chem. Hoppe-Seyler 376, 495-500 (1995).
90. Kossakowska, A. E., S. J. Urbanski, D. R. Edwards: Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas. Blood 77, 12475-12481 (1991).
91. Kossakowska, A. E., S. J. Urbanski, A. Watson, L. J. Hayden, D. R. Edwards: Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncology Res. 5, 19-28 (1993).
92. Kurschat, P., L. Graeve, A. Erren, P. Gatsios, S. Rose-John, E. Roeb, H. Tschesche, A. Koj, P. C. Heinrich: Expression of a biologically active murine tissue inhibitor of metalloproteinases-1 (TIMP-1) in baculovirus infected insect cells: purification and tissue distribution in the rat. Eur. J. Biochem 234, 485-491 (1995).
93. Leco, K. J., L. J. Hayden, R. R. Sharma, H. Rocheleau, A. H. Greenberg, D. R. Edwards: Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblasts. Gene 117, 209-217 (1992).
94. Leco, K. J., R. Khokha, N. Pavloff, S. P. Hawkes, D. R. Edwards: Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269, 9352-9360 (1994).
95. Lichte, A., H. Kolkenbrock, H. Tschesche: The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2. FEBS Lett. 397, 277-282 (1996).
96. Lin, C. Q., M. J. Bissell: Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J. 7, 737-743 (1993).
97. Lindsay, C. K., U. P. Thorgeirsson: Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas. Clin. Exp. Metastasis 13, 381-388 (1995).
98. Lindsay, C. K., U. P. Thorgeirsson, H. Tsuda, S. Hirohashi: Expression of tissue inhibitor of metalloproteinase-1 and type IV collagenase/gelatinase mRNAs in human breast cancer. Hum. Pathol. 28, 359-365 (1996).
99. Liotta, L. A., W. G. Stetler-Stevenson, P. S. Steeg: Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest. 9, 543-551 (1991).
100. Logan, S. K., M. J. Garabedian, C. E. Campbell, Z. Werb: Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J. Biol. Chem. 271, 774-782 (1996).
101. Lotz, M., P. A. Guerne: Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J. Biol. Chem. 266, 2017-2020 (1991).
102. Mann, J. S., M. S. Kindy, D. R. Edwards, T. E. Curry: Hormonal regulation of matrix metalloproteinase inhibitors in rat granulosa cells and ovaries. Endocrinology 128, 1825-1832 (1991).
103. Mann, J. S., M. S. Kindy, J. F. Hyde, M. R. Clark, T. E. Curry: Role of protein synthesis, prostaglandins, and estrogen in rat ovarian metalloproteinase inhibitor production. Biol. Reprod. 48, 1006-1013 (1993).
104. Maragoudakis, M. E., P. Peristeris, E. Missirlis, A. Aletras, P. Andriopoulou, G. Haralabopoulos: Inhibition of angiogenesis by anthracyclines and titanocene dichloride. Ann. N. Y. Acad. Sci. 732, 280-292 (1994).
105. Matrisian, L. M.: The matrix degrading metalloproteinases. BioEssays 14, 455-463 (1992).
106. Matsubara, M. K., K. D. Zoesle, M. E. Fini: Mechanisms of basement membrane dissolution preceding corneal ulceration. Invest. Ophthalmol. Vis. Sci. 32, 3221-3237 (1991).
107. Matsuzawa, K., K. Fukuyama, S. L. Hubbard, P. B. Dirks, J. T. Rutka: Transfection of an invasive human astrocytoma cell line with a TIMP-1 cDNA: modulation of astrocytoma invasive potential. J. Neuropathol. Exp. Neurol. 55, 88-96 (1996).
108. McCachren, S. S.: Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum. 34, 1085-1093 (1991).
109. McKeehan, W. L., Y. Sakagami, H. Hoshi, K. A. McKeehan: Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. J. Biol. Chem. 261, 5378-5383 (1986).
110. Mignatti, P., R. Tsuboi, E. Robbins, D. B. Rifkin: In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J. Cell Biol. 108, 671-682 (1989).
111. Montgomery, A. M. P., B. M. Mueller, R A. Reisfeld, S. M. Taylor, Y. A. DeClerck: Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res. 54, 5467-5473 (1994).
112. Moses, M. A., R. Langer: A metalloproteinase inhibitor as an inhibitor of neovascularization. J. Cell. Biochem. 47, 230-235 (1991).
113. Moses, M. A., J. Sudhalter, R. Langer: Identification of an inhibitor of neovascularization from cartilage. Science 248, 1408-1410 (1990).
114. Murate, T., K. Yamashita, H. Ohashi, Y. Kagami, K. Tsushita, T. Kinoshita, T. Hotta, H. Saito, S. Yoshida, K. J. Mori, T. Hayakawa: Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Exp. Hematol. 21, 169-176 (1993).
115. Murphy, A. N., E. J. Unsworth, W. G. Stetler-Stevenson: Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell. Physiol. 157, 351-358 (1993).
116. Murphy, G., T. E. Cawston, J. J. Reynolds: An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem. J. 195, 167-170 (1981).
117. Murphy, G., A. J. Docherty: The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol. 7, 120-125 (1992).
118. Murphy, G., A. Houbrechts, M. I. Cockett, R. A. O. Williamson, M. O'Shea, A. Docherty: The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 30, 8097-8102 (1991).
119. Murphy, G., P. Koklitis, A. F. Carne: Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitors. Biochem. J. 261, 1031-1034 (1989).
120. Murphy, G., J. J. Reynolds, R. M. Hembry: Metalloproteinases and cancer invasion and metastasis. Int. J. Cancer 44, 757-760 (1989).
121. Nagase, H., A. J. Barrett, J. F. Woessner, Jr.: Nomenclature and glossary of the matrix metalloproteinases. Matrix Suppl. 1, 421-424 (1992).
122. Nakatsukasa, H., K. Ashida, T. Higashi, S. Ohguchi, S. Tsuboi, N. Hino, N. Nouso, Y. Urabe, N. Kinugasa, K. Yoshida, S. Uematsu, M. Ishizaki, Y. Kobayashi, T. Tsuji: Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas. Hepatology 24, 82-88 (1996).
123. Niskanen, E., J. C. Gasson, J. Egrie, K. Wipf, D. W. Golde: Recombinant human erythroid potentiating activity enhances the effect of erythropoietin in mice. Eur. J. Haematol. 45, 267-270 (1990).
124. Niskanen, E., J. C. Gasson, C. D. Teates, D. W. Golde: In vivo effect of human erythroid-potentiating activity on hematopoiesis in mice. Blood 72, 806-810 (1988).
125. Nomura, S, B. L. M. Hogan, A. J. Wills, J. K. Heath, D. R. Edwards: Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA. Development 105, 575-583 (1989).
126. O'Shea, M., F. Willenbrock, R. A. Williamson, M. I. Crokett, R. B. Freedman, J. J. Reynolds, A. J. Docherty, G. Murphy: Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13. Biochemistry 31, 10146-10152 (1992).
127. Overall, C. M.: Regulation of tissue inhibitor of matrix metalloproteinase expression. Ann. N. Y. Acad. Sci. 732, 51-64 (1994).
128. Overall, C. M., J. Sodek: Concanavalin A produces matrix degradative phenotype in human fibroblasts. J. Biol. Chem. 265, 21141-21151 (1990).
129. Overall, C. M., J. L. Wrana, J. Sodek: Transcriptional and posttranscriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. J. Biol. Chem. 266, 14064-14071 (1991).
130. Pavloff, N., P. W. Staskus, N. S. Kishnani, S. P. Hawkes: A new inhibitor of metalloproteinase from chicken: ChIMP-3. J. Biol. Chem. 267, 17321-17326 (1992).
131. Polette, M., C. Clavel, P. Birembaut, Y. A. De Clerk: Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Path. Res. Pract. 189, 1052-1057 (1993).
132. Ray, J. M., W. G. Stetler-Stevenson: Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J. 14, 908-917 (1995).
133. Rechberger, T., J. F. Woessner, Jr.: Collagenase, its inhibitors, and decorin in the lower uterine segment in pregnant women. Am. J. Obstet. Gynecol. 168, 1598-1603 (1993).
134. Reich, R., D. Daphna-Iken, S. Y. Chun, M. Popliker, R. Slager, B. C. Adelmann-Grill, A. Tsafriri: Preovulatory changes in ovarian-expression of collagenases and tissue metalloproteinase inhibitor messenger ribonucleic acid: role of eicosanoids. Endocrinology 129, 1869-1875 (1991).
135. Rodgers, W. H., K. G. Osteen, L. M. Matrisian, M. Navre, L. C. Giudice, F. Gorstein: Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am. J. Obstet. Gynecol. 168, 253-260 (1993).
136. Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, M. Seiki: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370, 61-65 (1994).
137. Sato, T., A. Ito, Y. Mon, K. Yamashita, T. Hayakawa, H. Nagase: Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Biochem. J. 275, 645-650 (1991).
138. Schnaper, H. W., D. S. Grant, W. G. Stetler-Stevenson, R. Fridman, G. D'Orazi, A. N. Murphy, R. E. Byrd, M. Hoythya, T. R. Fuerst, D. L. French, J. P. Quigley, H. K. Kleinmann: Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell. Physiol. 156, 235-246 (1993).
139. Schultz, R. M., S. Silberman, B. Persky, A. S. Bajkowski, D. F. Carmichael: Inhibition of human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res. 48, 5539-5545 (1988).
140. Sellers, A., G. Murphy, M. C. Meikle, J. J. Reynolds: Rabbit bone collagenase inhibitor blocks the activity of other neutral metal loproteinases. Biochem. Biophys. Res. Commun. 87, 581-587 (1977).
141. Shapiro, S. D., E. J. Campbell, D. K. Kobayashi, H. G. Welgus: Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. J. Immunol. 146, 2724-2729 (1991).
142. Shapiro, S. D., D. K. Kobayashi, H. G. Welgus: Identification of TIMP-2 in human alveolar macrophages. J. Biol. Chem. 267, 13890-13894 (1992).
143. Soloway, P. D., C. M. Alexander, Z. Werb, R. Jaenisch: Targeted mutagenesis of TIMP-1 reveals that lung tumor invasion is influenced by TIMP-1 genotype of the tumor but not by that of the host. Oncogene 13, 2307-2314 (1996).
144. Stetler-Stevenson, W. G.: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 9, 289-303 (1990).
145. Stetler-Stevenson, W. G., N. Bersch, D. G. Golde: Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity. FEBS Lett. 296, 231-234 (1992).
146. Stetler-Stevenson, W. G., P. D. Brown, M. Onisto, A. T. Levy, L. A. Liotta: Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 265, 13933-13938 (1990).
147. Stetler-Stevenson, W. G., H. C. Krutzsch, L. A. Liotta: Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J. Biol. Chem. 264, 17374-17378 (1989).
148. Stricklin, G. P., H. G. Welgus: Human skin fibroblast collagenase inhibitors: purification and biochemical characterization. J. Biol. Chem. 258, 12252-12258 (1983).
149. Sun, Y., G. Hegamyer, N. H. Colburn: Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: one is homologous to human tissue inhibitor of metalloproteinases-3. Cancer Res. 54, 1139-1144 (1994).
150. Sun, Y., G. Hegamyer, H. Kim, K. Sithanandam, H. Li, R. Watts, N. H. Colburn: Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 and its promoter. Specific lack of expression in neoplastic JB6 cells may reflect altered gene methylation. J. Biol. Chem. 270, 19312-19319 (1995).
151. Sun, Y., H. Kim, M. Parker, W. G. Stetler-Stevenson, N. H. Colburn: Lack of suppression of tumor cell phenotype by overexpression of TIMP-3 in mouse JB6 tumor cells identification of a transfectant with increased tumorigenicity and invasiveness. Anticancer Res. 16, 1-7 (1996).
152. Takigawa, M., Y. Nishida, F. Suzuki, J. Kishi, K. Yamashita, T. Hayakawa: Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). Biochem. Biophys. Res. Commun. 171, 1264-1271 (1990).
153. Talhouk, R.S., M. J. Bissell, Z. Werb: Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J. Cell Biol. 118, 1271-1282 (1992).
154. Tanaka, K., Y. Iwamoto, Y. Ito, T. Ishibashi, Y. Nakabeppu, M. Sekiguchi, Y. Sugioka: Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. Cancer Res. 55, 2927-2935 (1995).
155. Taraboletti, G., A. Garofalo, D. Belotti, T. Drudis, P. Borsotti, E. Scanziani, P. D. Brown, R. Giavazzi: Inhibition of angiogenesis and murine hemagioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J. Natl. Cancer Inst. 87, 293-298 (1995).
156. Taylor, K. B., L. J. Windsor, N. C. M. Caterina, M. K. Bodden, J. A. Engler: The mechanism of inhibition of collagenase by TIMP-1. J. Biol. Chem. 271, 23938-23945 (1996).
157. Thorgeirsson, U. P., L. A. Liotta, T. Kalebic, I. M. Margulies, K. Thomas, M. Rios-Candelore, R. G. Russo: Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. J. Natl. Cancer Inst. 69, 1049-1054 (1982).
158. Thorgeirsson, U. P., T. Turpeenniemi-Hujanen, J. E. Williams, E. H. Westin, C. A. Heilman, J. E. Talmadge, L. A. Liotta: NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol. Cell. Biol. 5, 259-262 (1985).
159. Thorgeirsson, U. P., H. Yoshiji, C. C. Sinha, D. E. Gomez: Breast cancer, tumor neovasculature and the effect of tissue inhibitor of metalloproteinases-1 (TIMP-1) on angiogenesis. In Vivo 10, 137-144 (1996).
160. 78QTIMP-1. Proteins 17, 435-437 (1993).
161. Tsuchiya, Y., H. Sato, Y. Endo, Y. Okada, M. Mai, T. Sasaki, M. Seiki: Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. Cancer Res. 53, 1397-1402 (1993).
162. Urbanski, S. J., D. R. Edwards, N. Hershfield, S. A. Huchcroft, E. Shaffer, L. Sutherland, A. E. Kossakowska: Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diagn. Mol. Pathol. 2, 81-89 (1993).
163. Van den Brule, F. A., J. Engel, W. G. Stetler-Stevenson, F. T. Liu, M. E. Sobel, V. Castronuovo: Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cells. Int. J. Cancer 52, 653-657 (1992).
164. Vine, N., J. T. Powell: Metalloproteinases in degenerative aortic disease. Clin. Sci. 82, 233-239 (1991).
165. Visscher, D. W., M. Hoyhtya, S. K. Ottosen, C. Liang, F. Sarkar, J. D. Crissman, R. Fridman: Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int. J. Cancer 59, 339-344 (1994).
166. Wagner, S. N., H. M. Ockenfels, C. Wagner, H. P. Soyer, M. Goos: Differential expression of tissue inhibitor of metalloproteinases-2 by cutaneous squamous and basal cell carcinomas. J. Invest. Dermatol. 106, 321-326 (1996).
167. Weber, B. H. F., G. Vogt, R. C. Pruett, H. Stohr, U. Felbor: Mutations in the tissue inhibitor of metalloproteinase 3 (TIMP-3) in patients with Serby's fundus dystrophy. Nature Genetics 8, 352-356 (1994).
168. Wick, M., C. Burger, S. Brusselbach, F. C. Lucibello, R. Muller: A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during Gl progression, mitogenic stimulation, diferentiation and senescence. J. Biol. Chem. 269, 18953-18960 (1994).
169. Wilde, C. G., P. R. Hawkins, R. T. Coleman, W. B. Levine, A M. Delegeane, P. M. Okamoto, L. Y. Ito, R. W. Scott, J. J. Seilhamer: Cloning and characterization of human tissue inhibitor of metalloproteinases-3. DNA Cell Biol. 13, 711-718 (1994).
170. Williamson, R. A., F. A. O. Marston, S. Angal, P. Koklitis, M. Panico, H. R. Morris, A. F. Carne, B. J. Smith, T. J. R. Harris, R. B. Freedman: Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). Biochem. J. 268, 267-274 (1990).
171. Williamson, R. A., B. J. Smith, S. Angal, G. Murphy, R. B. Freedman: Structural analysis of tissue inhibitor of metalloproteinases-1 (TIMP-1) by tryptic peptide mapping. Biochim. Biophys. Acta 1164, 8-16 (1993).
172. Woessner, J. F., Jr.: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-2155 (1991).
173. Woessner, J. F., Jr.: The family of matrix metalloproteinases. Ann. N. Y. Acad. Sci. 732, 11-21 (1994).
174. Yang, T. T., S. P. Hawkes: Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA 89, 10676-10680 (1992).
175. Yoshiji, H., D. E. Gomez, U. P. Thorgeirsson: Enhanced RNA expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in human breast cancer. Int. J. Cancer 69, 131-134 (1996).
176. Zhu, C., J. F. Woessner, Jr.: A tissue inhibitor of metalloproteinases and α-macroglobulins in the ovulating rat ovary: possible regulators of collagen matrix breakdown. Biol. Reprod. 45, 334-342 (1991).